Ceftriaxone and Pregnancy
While no human studies have examined ceftriaxone and pregnancy, ceftriaxone caused no side effects to fetuses in previous studies on animals. As a result of these studies, the FDA classifies ceftriaxone as a pregnancy Category B medicine. A pregnant woman may take it if her healthcare provider decides that its benefits outweigh any possible risks to her unborn child.
Is Ceftriaxone Safe During Pregnancy?The U.S. Food and Drug Administration (FDA) considers ceftriaxone (Rocephin®) a pregnancy Category B medicine, which means that it has not been studied in pregnant women. However, when studied in pregnant animals, ceftriaxone showed no negative effects on unborn babies.
Ceftriaxone and Pregnancy Category BThe U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is assigned to medicines that do not cause side effects to the fetus in animal studies, but for which no human studies on pregnant women have been done.
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category B medicine may be given to a pregnant woman if the healthcare provider believes that the benefits to the pregnant woman outweigh any possible risks to the unborn child.
If you are pregnant and have been prescribed ceftriaxone, let your healthcare provider know. Your healthcare provider will consider both the benefits and risks of ceftriaxone during pregnancy before making a recommendation for your particular situation.